Wockhardt Bio financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
590.24M | 406.28M | 417.95M | 331.11M | 336.15M | 337.03M | 315.14M | 264.94M | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
55.26% | 58.51% | 62.88% | 51.44% | 49.19% | 48.71% | 54.73% | 56.50% | 0.00% | 0.00% |
| OM | Operating Margin |
|
14.22% | 12.26% | 9.77% | -14.17% | -3.29% | -2.42% | 8.35% | 4.56% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | 0.00 | ||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
46.95m | 46.95m | 51.95m | 51.95m | 51.95m | 0m | 51.95m | 0m | 0m | 51.95m |
| OCF | Operating Cash Flow |
|
214.24M | 5.26M | 59.15M | 3.05M | 49.48M | 8.81M | 51.06M | 68.06M | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
0.00M | -1.76M | 44.05M | -10.21M | 27.08M | -3.41M | 45.65M | 55.85M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
4.73 | -0.08 | 0.55 | -0.67 | -1.10 | -0.66 | 0.39 | 1.46 | 0.00 | 0.00 |